University of York-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of York - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013350
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of York (York) is an educational and research university that offers academic research and teaching services. The university offers commercial facilities and services, funding collaborative research, knowledge transfer partnerships, professional development and training, consultancy, investment and licensing opportunities, contracting research and student services. It offers teaching services for archaeology, biology, chemistry, computer science, economics and related studies, electronics, environment, health economics, health sciences, history, sociology, theatre, film and television, philosophy, psychology, medicine, natural sciences, music, management, law and others. York also offers consultancy services for external organizations and universities. The university has partnership with other universities. York is headquartered in York, the UK.

University of York – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of York, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of York, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of York, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of York, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of York, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
University of York, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
University of Twente, Luxembourg Institute of Health and University of York Enter into Research Collaboration 10
Licensing Agreements 11
Crown Bioscience Enters into Licensing Agreement with University of York 11
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University of York For Prostate Cancer Stem Cell Assets 12
University of York – Key Competitors 13
University of York – Key Employees 14
University of York – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Government and Public Interest 16
Nov 30, 2016: EPSRC Grant for Organic Synthesis with the University of York 16
Aug 08, 2016: New drugs hope to fight neglected tropical diseases 17
Jan 07, 2016: Spin-out wins Innovate UK grant to develop ‘virtual’ drug lab 18
Product News 19
Jun 19, 2017: Scientists step closer to drug treatment for hepatitis B 19
Jan 04, 2017: Scientists develop new antibiotic for gonorrhea 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
University of York, Pharmaceuticals & Healthcare, Key Facts 2
University of York, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of York, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of York, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of York, Deals By Therapy Area, 2011 to YTD 2017 8
University of York, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
University of Twente, Luxembourg Institute of Health and University of York Enter into Research Collaboration 10
Crown Bioscience Enters into Licensing Agreement with University of York 11
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University of York For Prostate Cancer Stem Cell Assets 12
University of York, Key Competitors 13
University of York, Key Employees 14
University of York, Other Locations 15

★海外企業調査レポート[University of York-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Entegris Inc (ENTG):企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • Cosmo Oil Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Cosmo Oil Co Ltd (Cosmo Oil), a subsidiary of Cosmo Energy Holdings Co Ltd, procures oil and refines, distributes, imports and exports petroleum products and petrochemical products. The company operates Chiba, Yokkaichi and Sakai refineries. These refineries produce petroleum products such a …
  • Sanofi-Aventis Korea Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi-Aventis Korea Co Ltd (Sanofi-Aventis), a subsidiary of Sanofi is a developer, manufacturer and distributor of generic drugs and medical equipment. The company’s products include note vials lantus, lantus state solo star, she feeds the main vial la, feed her a solo star la shares, elro …
  • Borders & Southern Petroleum plc (BOR):企業の財務・戦略的SWOT分析
    Summary Borders & Southern Petroleum Plc (Borders & Southern Petroleum) is an oil and gas company that offers exploration and development of hydrocarbons. The company holds interests in three production licenses in the Falkland Islands located south-east of the Islands. Its production licenses provi …
  • MicroPort Scientific Corp (853):企業の財務・戦略的SWOT分析
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company which develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, e …
  • Biohaven Pharmaceutical Holding Company Ltd (BHVN):製薬・医療:M&Aディール及び事業提携情報
    Summary Biohaven Pharmaceutical Holding Company Ltd (Biohaven), a subsidiary of Portage Biotech Inc, is a clinical-stage biopharmaceutical company that develops late-stage product candidates for neurological diseases. The company develops small molecule CGRP receptor antagonist platform that include …
  • McWane Inc:企業の戦略的SWOT分析
    McWane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • BBA Aviation plc (BBA):企業の財務・戦略的SWOT分析
    BBA Aviation plc (BBA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Global Foundries Inc:企業の戦略・SWOT・財務情報
    Global Foundries Inc - Strategy, SWOT and Corporate Finance Report Summary Global Foundries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PharmAust Ltd (PAA):企業の財務・戦略的SWOT分析
    Summary PharmAust Ltd (PAA) is a clinical-stage company that focuses on the development of targeted cancer therapeutics for the treatment of human and veterinary cancers. The company’s lead product candidate Monepantel is a small molecule that has been developed to treat parasite infections in food …
  • T-System Inc:医療機器:M&Aディール及び事業提携情報
    Summary T-System Inc (T-System) is a provider of healthcare IT solutions with focus on emergency department documentation. T-System develops solutions for the episode-based care market, which includes emergency departments (EDs) in hospitals, freestanding emergency centers and urgent care centers. B …
  • Aesculap Inc:企業の製品パイプライン分析2018
    Summary Aesculap Inc (Aesculap) is a medical device company that offers medical implants, surgical implants, and other related devices. The company’s products comprise neurosurgery products, power systems, sterile processing products, surgical instruments, and wound closure products. It offers servi …
  • Gr. Sarantis S.A. (SAR):企業の財務・戦略的SWOT分析
    Gr. Sarantis S.A. (SAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • IndigoVision Group plc (IND):企業の財務・戦略的SWOT分析
    Summary IndigoVision Group plc (IndigoVision) is a developer, manufacturer and distributor of end-to-end IP security management systems. The company’s products include management software, cameras and encoders, specialized cameras, body worn video, integration and recorders. Its camera and encoder’s …
  • Bsquare Corporation (BSQR):企業の財務・戦略的SWOT分析
    Bsquare Corporation (BSQR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Swiss Post Ltd:企業の戦略的SWOT分析
    Swiss Post Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • LifeLabs Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeLabsInc (LifeLabs), formerly MDS Diagnostic Services is a laboratory service provider that diagnoses, treats, monitors and prevent diseases in patients. The laboratory's services include clinical studies and services, drug and alcohol screening, employee wellness, hospital lab services, …
  • Warner Media LLC.:企業の戦略・SWOT・財務分析
    Warner Media LLC. - Strategy, SWOT and Corporate Finance Report Summary Warner Media LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Martifer SGPS SA (MAR):企業の財務・戦略的SWOT分析
    Martifer SGPS SA (MAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • bioMerieux Inc-医療機器分野:企業M&A・提携分析
    Summary bioMerieux Inc (bioMerieux), a subsidiary of Institut Merieux SA is a provider of diagnostic solutions. The company offers its products for clinical solutions which include blood culture, cancer diagnostics, cardiovascular disease, cardiovascular pathology, clinical laboratories, companion d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆